Pulmonology Education and CME

Select a Specialty

Diagnosis and Treatment of ILD with a Progressive Lung Disease Phenotype: Clinical Implications of Emerging Data
CME

Diagnosis and Treatment of ILD with a Progressive Lung Disease Phenotype: Clinical Implications of Emerging Data

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Expiration Date: 11/15/2019
Credit Type(s): CME | Credit: 1

The arrival of new therapeutic options for Idiopathic Pulmonary Fibrosis (IPF) has stimulated vigorous interest in the Interstitial Lung Diseases (ILDs) that are…

go to activity»
Early Intervention in Cystic Fibrosis: CFTR-Related Organ Damage Progression From in Utero Through Adulthood
CMEABIM MOCCNE

Early Intervention in Cystic Fibrosis: CFTR-Related Organ Damage Progression From in Utero Through Adulthood

This activity is supported by an educational grant from Vertex Pharmaceuticals Incorporated.

Expiration Date: 11/29/2019
Credit Type(s): CME / CNE | Credit: 1.8

Learn about early interventions and how to address GI tract and lung organ damage progression in CF. Expert faculty, animations, interactive polling and infographic…

go to activity»
Optimizing COPD Management
CMECNE

Optimizing COPD Management

This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP

Expiration Date: 1/6/2020
Credit Type(s): CME / CNE / AAFP | Credit: 1.2

Identifying and treating patients with Chronic Obstructive Pulmonary Disease (COPD) is urgent in light of the mortality, morbidity and economic consequences of the…

go to activity»
COPD101: Basic Diagnosis and Management
CMECNE

COPD101: Basic Diagnosis and Management

This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP

Expiration Date: 1/6/2020
Credit Type(s): CME / CNE / AAFP | Credit: 1.2

Identifying and treating patients with Chronic Obstructive Pulmonary Disease (COPD) is urgent in light of the mortality, morbidity and economic consequences of the…

go to activity»
Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Expiration Date: 12/12/2019
Credit Type(s): CME | Credit: 1.25

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation of CMV infection in a seropositive individual…

go to activity»
Personalized Medicine in Nontuberculous Mycobacteria: Best Practices in Diagnosing and Managing NTM
CME

Personalized Medicine in Nontuberculous Mycobacteria: Best Practices in Diagnosing and Managing NTM

This activity is supported by an educational grant from Insmed Incorporated.

Expiration Date: 11/18/2019
Credit Type(s): CME | Credit: 1

The goal of this 60-minute online enduring program is to improve the awareness, knowledge, and competency of pulmonologists and infectious disease physicians in the…

go to activity»
COPD Patient-Centered Care – Adherence with Therapy
CMECNE

COPD Patient-Centered Care – Adherence with Therapy

This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP

Expiration Date: 1/6/2020
Credit Type(s): CME / CNE / AAFP | Credit: 1.2

Identifying and treating patients with Chronic Obstructive Pulmonary Disease (COPD) is urgent in light of the mortality, morbidity and economic consequences of the…

go to activity»
COPD Diagnosis – By the Numbers
CMECNE

COPD Diagnosis – By the Numbers

This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP

Expiration Date: 1/6/2020
Credit Type(s): CME / CNE / AAFP | Credit: 1.2

Identifying and treating patients with Chronic Obstructive Pulmonary Disease (COPD) is urgent in light of the mortality, morbidity and economic consequences of the…

go to activity»
Interstitial Lung Disease: Altering The Disease Course Through Effective And Individualized Management
CMECNE

Interstitial Lung Disease: Altering The Disease Course Through Effective And Individualized Management

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Expiration Date: 10/30/2019
Credit Type(s): CME / CME | Credit: 1.5

Steven Nathan, MD, and Imre Noth, MD, provide their insights into the challenging management of patients with an interstitial lung disease (ILD). They discuss key…

go to activity»